CAS 864750-70-9
:1-[2-[[4-[[4-(Aminocarbonyl)-1-piperidinyl]methyl]benzoyl]methylamino]ethyl]-4-piperidinyl N-[1,1′-biphenyl]-2-ylcarbamate
Description:
The chemical substance known as 1-[2-[[4-[[4-(Aminocarbonyl)-1-piperidinyl]methyl]benzoyl]methylamino]ethyl]-4-piperidinyl N-[1,1′-biphenyl]-2-ylcarbamate, with the CAS number 864750-70-9, is a complex organic compound characterized by its multi-functional structure. It features a biphenyl moiety, which is significant for its potential biological activity, and incorporates piperidine rings that contribute to its pharmacological properties. The presence of an aminocarbonyl group suggests that it may exhibit interactions with biological targets, possibly influencing enzyme activity or receptor binding. This compound is likely to be soluble in organic solvents, and its stability may be influenced by environmental factors such as pH and temperature. Given its intricate structure, it may be of interest in medicinal chemistry, particularly in the development of therapeutic agents. However, specific details regarding its biological activity, toxicity, and applications would require further investigation through empirical studies and literature review.
Formula:C35H43N5O4
InChI:InChI=1S/C35H43N5O4/c1-38(34(42)29-13-11-26(12-14-29)25-40-19-15-28(16-20-40)33(36)41)23-24-39-21-17-30(18-22-39)44-35(43)37-32-10-6-5-9-31(32)27-7-3-2-4-8-27/h2-14,28,30H,15-25H2,1H3,(H2,36,41)(H,37,43)
InChI key:InChIKey=FYDWDCIFZSGNBU-UHFFFAOYSA-N
SMILES:N(C(OC1CCN(CCN(C(=O)C2=CC=C(CN3CCC(C(N)=O)CC3)C=C2)C)CC1)=O)C4=C(C=CC=C4)C5=CC=CC=C5
Synonyms:- Carbamic acid, N-[1,1′-biphenyl]-2-yl-, 1-[2-[[4-[[4-(aminocarbonyl)-1-piperidinyl]methyl]benzoyl]methylamino]ethyl]-4-piperidinyl ester
- TD 4208
- 1-[2-[[4-[[4-(Aminocarbonyl)-1-piperidinyl]methyl]benzoyl]methylamino]ethyl]-4-piperidinyl N-[1,1′-biphenyl]-2-ylcarbamate
- Carbamic acid, [1,1′-biphenyl]-2-yl-, 1-[2-[[4-[[4-(aminocarbonyl)-1-piperidinyl]methyl]benzoyl]methylamino]ethyl]-4-piperidinyl ester
- Revefenacin
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 12 products.
1-(2-(3-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate
CAS:Formula:C35H43N5O4Purity:%Color and Shape:SolidMolecular weight:597.7470Ref: IN-DA00H1KA
1gTo inquire1mg40.00€5mg61.00€10mg89.00€25mg116.00€50mg193.00€100mg235.00€250mg528.00€1-(2-(3-((4-Carbamoylpiperidin-1-Yl)Methyl)-N-Methylbenzamido)Ethyl)Piperidin-4-Yl [1,1'-Biphenyl]-2-Ylcarbamate
CAS:1-(2-(3-((4-Carbamoylpiperidin-1-Yl)Methyl)-N-Methylbenzamido)Ethyl)Piperidin-4-Yl [1,1'-Biphenyl]-2-YlcarbamatePurity:98%Molecular weight:597.75g/molRevefenacin
CAS:Revefenacin (TD-4208) is a mAChR antagonist has a high affinity on M3 receptor( Ki : 0.18 nM),and potentially useful for the treatment of respiratory disease.Formula:C35H43N5O4Purity:98.12%Color and Shape:SolidMolecular weight:597.75Desamino-hydroxy-des(1'-(N-([1,1'-biphenyl]-2-yl)formamidyl)) Revefenacin
CAS:Controlled ProductFormula:C22H33N3O4Color and Shape:NeatMolecular weight:403.515Revefenacin
CAS:<p>Revefenacin is a long-acting anticholinergic agent that is used to treat chronic bronchitis. It is administered via the mouth and lungs. Revefenacin has shown efficacy in treating chronic bronchitis, with a reduction in the number of exacerbations and improvement in lung function. Revefenacin was approved by the United States Food and Drug Administration (USFDA) as a long-acting anticholinergic drug for the treatment of chronic bronchitis. The most common adverse effects are dry mouth, blurred vision, constipation, diarrhea, dizziness, fatigue, headache, impotence, insomnia, nausea, urinary retention. !--END-->/li></p>Formula:C35H43N5O4Purity:Min. 95%Molecular weight:597.75 g/mol






